Skip to main content

Table 3 Dose parameters to organs at risk for each patient (1–6) and planning strategy (S1-S4) given per patient and as a cohort median

From: Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer

  Organs at risk
No Stomach Duodenum Small Bowel Large Bowel Spinal Cord Liver Left Kidney Right Kidney
Dmax [Gy] D2% [Gy] V45Gy [%] V50Gy [%] Dmax [Gy] D2% [Gy] V45Gy [%] D2% [Gy] V15Gy [ccm] D2% [Gy] V15Gy [ccm] Dmax [Gy] D2% [Gy] Dmean [Gy] V30Gy [%] Dmean [Gy] V12Gy [%] V20Gy [%] Dmean [Gy] V12Gy [%] V20Gy [%]
(S1) 1 49.8 29.3 0.1 0.0 51.6 146.6 46.9 121.1 37.3 26.7 8.5 6.9 12.3 52.3 30.8 9.4 40.6 23.5
2 42.6 18.7 0.0 0.0 42.1 58.1 14.6 10.2 36.9 33.9 1.2 1.0 2.2 7.8 3.3 11.7 42.4 30.2
3 42.6 19.4 0.0 0.0 51.1 87.8 0.1 0.0 42.3 36.0 4.6 5.5 12.2 44.7 31.9 12.7 44.3 33.3
4 64.4 43.7 1.8 1.1 68.2 63.3 71.5 26.7 39.6 24.1 34.3 36.8 33.5 2.4 2.1 9.8 35.4 26.7 11.1 40.6 31.4
5 68.9 50.6 8.5 2.5 59.1 51.8 40.8 37.3 77.7 6.2 5.6 42.1 37.8 4.0 4.4 12.6 46.0 27.0 12.1 44.8 32.3
6 67.3 57.3 9.0 5.5 68.1 63.4 41.4 60.9 50.4 16.3 39.3 38.3 30.8 3.5 1.8 16.5 57.0 37.7 17.1 55.5 35.0
Median 57.1 36.5 1.0 0.5 68.1 63.3 41.4 46.6 67.9 15.5 22.3 37.8 33.7 3.8 3.3 12.3 45.4 28.9 11.9 43.4 31.9
(S2) 1 48.3 32.8 0.1 0.0 51.5 145.0 46.6 128.0 21.7 16.1 9.0 8.4 12.0 51.2 29.5 4.0 15.1 6.6
2 42.6 19.9 0.0 0.0 40.8 75.0 27.0 53.8 24.6 21.1 4.9 1.3 1.5 4.5 1.0 7.4 29.4 12.4
3 45.2 17.2 0.0 0.0 50.1 108.2 3.6 5.7 25.4 23.0 7.8 6.0 10.7 41.7 23.9 1.1 0.8 0.0
4 60.4 38.3 1.0 0.4 67.3 62.5 69.5 28.0 48.5 29.8 190.5 25.4 22.3 6.6 2.5 8.1 28.6 20.2 2.2 5.6 0.3
5 68.0 50.4 6.7 2.3 58.9 52.1 34.1 36.8 75.0 26.9 99.5 23.1 21.8 7.2 4.6 11.5 44.9 25.2 4.1 14.5 6.4
6 65.9 55.1 7.4 4.2 67.3 63.9 39.8 59.1 55.6 27.8 119.7 22.2 19.4 9.2 4.0 12.3 49.1 29.1 1.4 3.1 0.0
Median 54.4 35.6 0.5 0.2 67.3 62.5 39.8 45.4 75.0 27.4 109.6 23.9 21.5 7.5 4.3 11.1 43.3 24.5 3.1 10.0 3.4
(S3) 1 49.3 30.7 0.1 0.0 51.5 141.2 47.1 114.8 27.0 20.1 10.5 6.7 9.8 47.1 10.2 6.3 27.9 0.5
2 43.4 17.6 0.0 0.0 39.3 61.7 19.0 17.8 28.4 24.8 6.1 1.2 0.8 1.4 0.0 8.6 35.1 11.6
3 41.3 18.3 0.0 0.0 49.9 89.9 0.1 0.0 32.2 28.5 8.3 5.8 7.8 33.8 6.3 7.3 30.0 3.1
4 61.0 40.3 1.2 0.5 67.2 62.5 66.7 27.6 43.6 25.6 77.3 26.8 24.1 7.2 2.4 5.6 23.4 4.5 8.8 41.5 4.5
5 68.3 50.6 7.5 2.6 55.2 51.7 37.2 37.8 79.6 16.1 18.2 29.2 25.7 7.6 4.6 10.0 42.6 20.8 8.4 41.8 8.0
6 66.5 55.2 8.2 4.5 67.5 64.7 37.4 60.0 54.0 21.0 64.9 30.9 27.6 6.8 0.7 10.6 43.3 19.7 7.6 29.3 0.4
Median 55.2 35.5 0.6 0.3 67.2 62.5 37.3 44.6 70.7 20.0 41.5 28.8 25.3 7.4 3.5 8.8 38.2 8.3 8.0 32.6 3.8
(S4) 1 50.5 31.7 0.3 0.0 51.7 140.0 47.8 112.6 32.3 28.0 9.4 6.2 10.6 50.1 7.8 8.2 34.6 12.0
2 43.2 20.7 0.0 0.0 40.4 60.1 15.5 11.0 28.7 25.2 6.3 1.1 0.2 0.0 0.0 9.5 37.0 17.1
3 43.3 16.8 0.0 0.0 53.8 77.5 0.1 0.0 28.8 25.9 8.4 5.3 6.6 25.6 6.5 6.8 23.1 4.7
4 60.6 41.4 1.3 0.6 66.4 62.6 67.3 28.6 49.2 25.0 75.5 27.7 25.4 7.0 2.3 1.2 2.9 1.0 9.4 39.6 6.5
5 68.3 50.3 7.2 2.3 55.6 51.5 35.0 34.4 77.3 15.7 18.9 27.5 24.4 6.5 4.1 11.5 46.8 21.3 7.4 28.8 10.9
6 66.2 55.0 8.4 4.3 67.9 64.0 39.4 59.7 53.6 19.2 66.5 27.8 24.9 7.0 0.6 10.7 43.6 20.3 1.4 0.3 0.0
Median 55.6 36.5 0.8 0.3 66.4 62.6 39.4 46.0 68.7 17.5 42.7 28.2 25.3 7.0 3.2 8.6 34.6 7.1 7.8 31.7 8.7
  1. Abbreviations: Dmax maximum dose, Dmean mean dose, VxGy volume receiving x-Gy, D2% near dose maximum; dose received by 2% of the volume